由AMP激活的蛋白激酶的催化异型差异调节IMPDH活性和光受体神经元功能
Tae Jun Lee1,2, Yo Sasaki3, Philip A Ruzycki1,3
1John F. Hardesty, MD Department of Ophthalmology and Visual Sciences.
JCI insight
|January 16, 2024
概括
AMP激活蛋白激酶 (AMPK) 异型PRKAA2,而不是PRKAA1,对于光受体细胞代谢和功能至关重要. 在PRKAA2缺乏的小鼠中准IMPDH改善了视觉功能,这表明了一种新的治疗方法.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 细胞的新陈代谢
背景情况:
- AMP激活蛋白激酶 (AMPK) 对于保持光受体神经元中的能量平衡 (ATP平衡) 是必不可少的.
- 在这些专门的神经元中,两个催化性α子单元异型,PRKAA1和PRKAA2的特定作用在很大程度上是未知的.
研究的目的:
- 研究AMPK的PRKAA1和PRKAA2异型在小鼠光受体代谢和视觉功能的不同功能.
- 为了确定 PRKAA2 特定光受体功能障碍背后的分子机制.
主要方法:
- 使用了缺少PRKAA1或PRKAA2在棒光受体中的淘汰赛小鼠模型.
- 评估了代谢变化 (cGMP,GTP,ATP水平),视觉功能 (电网膜学) 和光受体结构 (传输电子显微镜).
- 采用蛋白质组学来识别分子标,并通过药理抑制验证发现.
主要成果:
- 在杆光受体中失去PRKAA2,但不是PRKAA1,导致cGMP,GTP和ATP水平发生变化,表明异构体特定的代谢调节.
- PRKAA2 缺乏导致光受体外段的视觉功能缺陷和结构异常,与功能障碍相一致,而不是神经退行.
- 蛋白组学确定了因诺辛单酸脱酶 (IMPDH) 作为PRKAA2相关光受体功能障碍的关键参与者.
结论:
- 在调节光受体代谢和视觉功能方面,PRKAA2发挥着关键的,异型特异性的作用.
- IMPDH是PRKAA2-依赖光受体功能障碍的分子驱动因素.
- 抑制IMPDH代表了与PRKAA2功能障碍相关的视力障碍的有前途的治疗策略.
相关概念视频
01:22Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
01:07MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
01:22Photoreceptors and Visual Pathways
6.0K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.0K
01:25cAMP-dependent Protein Kinase Pathways
6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
01:15Amplifying Signals via Second Messengers
7.0K
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
7.0K